CollPlant Biotechnologies Ltd. logo

CollPlant Biotechnologies Ltd. (CLGN)

Market Open
19 Oct, 04:15 PM
NASDAQ (NMS) NASDAQ (NMS)
$
3. 61
-0.02
-0.4138%
$
4.7M Market Cap
- P/E Ratio
- Div Yield
20,719 Volume
-1.42 Eps
$ 3.62
Previous Close
Investors:
Add Transaction
Day Range
3.5 3.69
Year Range
2.64 26.8
Want to track CLGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing Transcript

CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing Transcript

CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing Transcript

Seekingalpha | 1 month ago
CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q4 2024 Earnings Conference Call March 26, 2025 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Conference Call Participants Swayampakula Ramakanth - H.C.

Seekingalpha | 1 year ago
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd (NASDAQ:CLGN ) Q3 2024 Earnings Conference Call November 27, 2024 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Operator Greetings, and welcome to the CollPlant Biotechnologies Third Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode.

Seekingalpha | 1 year ago
CollPlant (CLGN), Stratasys Initiate Study for Breast Implants

CollPlant (CLGN), Stratasys Initiate Study for Breast Implants

CollPlant (CLGN) and Stratasys announce the initiation of a pre-clinical study to focus on the ability of implants to grow natural breast tissue and completely degrade over time.

Zacks | 2 years ago
CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q2 2024 Earnings Conference Call August 20, 2024 10:00 AM ET Company Participants Dan Ferry - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Conference Call Participants Sean Lee - H.C.

Seekingalpha | 2 years ago